Position in MRK
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,859,206,929
+$544,911,309 QoQ
Shares Held
15,456,039
+23.8% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 80.95599396455975.ToString("F0")%
Shared 11.15568484266894.ToString("F0")%
None 7.8883211927713175.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $16,975,027,289 across 14 Drug Manufacturers - General names. MRK ranks #3 (11.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,832,514 | $3,870,099,719 | |
| 2 | LLY |
ELI LILLY & Co
|
3,895,925 | $3,583,354,934 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
15,456,039 | $1,859,206,929 | |
| 4 | ABBV |
AbbVie Inc.
|
7,411,238 | $1,611,870,150 | |
| 5 | NVS |
Novartis AG
|
8,110,116 | $1,238,820,217 | |
| 6 | AMGN |
Amgen Inc
|
3,304,344 | $1,162,633,435 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,762,589 | $1,137,951,021 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
7,722,929 | $1,076,344,612 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,859,206,929 | 15,456,039 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,314,295,620 | 12,486,183 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $912,954,783 | 10,877,574 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $840,927,919 | 10,623,142 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $979,661,014 | 10,914,227 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,151,733,180 | 11,577,535 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $805,995,277 | 7,097,528 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $767,798,436 | 6,201,926 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $761,463,919 | 5,770,852 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $647,527,013 | 5,939,525 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $900,522,487 | 8,747,183 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,111,634,718 | 9,633,718 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $1,011,055,126 | 9,503,291 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,027,653,291 | 9,262,310 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $756,658,413 | 8,786,094 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $709,421,756 | 7,781,307 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $618,093,726 | 7,533,135 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $694,775,244 | 9,065,439 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $735,475,016 | 9,791,972 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $770,993,737 | 9,913,768 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $746,372,394 | 10,146,554 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $794,902,928 | 10,184,091 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $818,473,806 | 10,340,689 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $735,163,864 | 9,963,163 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $699,862,761 | 9,532,837 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||